International Journal of Diabetes and Endocrinology

Submit a Manuscript

Publishing with us to make your research visible to the widest possible audience.

Propose a Special Issue

Building a community of authors and readers to discuss the latest research and develop new ideas.

Research Article |

Analysis of C-reactive Protein as an Inflammation Biomarker in Type-2 Diabetes Mellitus Patients at Minahasa, North Sulawesi, Indonesia

C-reactive protein is a non-specific acute phase reactant produced by the liver and endothelial cells. Inflammation or acute infections cause a rise in C-reactive protein, which can be measured to determine the risk of cardiovascular disease. The hs-CRP test can detect CRP at lower concentrations because it is more sensitive, making it more effective than conventional CRP testing methods. This study aimed determine the relationship between hs-CRP levels and fasting blood glucose, and to examine whether there were differences in hs-CRP levels in patients with type-2 diabetes mellitus with or without hypertension, in Minahasa, North Sulawesi, Indonesia. A total of 123 diabetes mellitus patients were included in this cross-sectional study. Subjects were tested for blood pressure, body mass index, fasting blood glucose, and hs-CRP levels. The correlation between hs-CRP and fasting blood glucose had a correlation coefficient (r) 0.404 and p-value 0.000 (<0.05). The average hs-CRP level in type-2 diabetes mellitus patients with hypertension was 148.8 ± 24.9 mg/dL and 55.1 ± 54.0 mg/dL without hypertension. In conclusion, there was a significant relationship between hs-CRP and fasting blood glucose levels, and type-2 diabetes mellitus patients with hypertension also had greater hs-CRP levels than those without hypertension. This suggests that hs-CRP can be used to evaluate a diabetic patient's risk for cardiovascular disease.

Diabetes Mellitus, Fasting Blood Glucose, hs-CRP

APA Style

Diana Shintawati Purwanto, Sylvia Ritta Marunduh, Stefana Helena Margaretha Kaligis. (2023). Analysis of C-reactive Protein as an Inflammation Biomarker in Type-2 Diabetes Mellitus Patients at Minahasa, North Sulawesi, Indonesia . International Journal of Diabetes and Endocrinology, 8(4), 50-53. https://doi.org/10.11648/j.ijde.20230804.12

ACS Style

Diana Shintawati Purwanto; Sylvia Ritta Marunduh; Stefana Helena Margaretha Kaligis. Analysis of C-reactive Protein as an Inflammation Biomarker in Type-2 Diabetes Mellitus Patients at Minahasa, North Sulawesi, Indonesia . Int. J. Diabetes Endocrinol. 2023, 8(4), 50-53. doi: 10.11648/j.ijde.20230804.12

AMA Style

Diana Shintawati Purwanto, Sylvia Ritta Marunduh, Stefana Helena Margaretha Kaligis. Analysis of C-reactive Protein as an Inflammation Biomarker in Type-2 Diabetes Mellitus Patients at Minahasa, North Sulawesi, Indonesia . Int J Diabetes Endocrinol. 2023;8(4):50-53. doi: 10.11648/j.ijde.20230804.12

Copyright © 2023 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

1. Young EE, Okafor CN, Okwara CC. Diabetes mellitus, associated co-morbidities and complications - A review. Int Res J Med Med Sci. 2016; 07 (03): 47-55. doi: 10.14303/jmms.2016.302.
2. Purwanto DS, Mewo YM, Jim EL, Laloan RJ, Raranta HPT, Kepel BJ. Electrolyte levels analysis on diabetes mellitus patients in Noongan Regional General Hospital, North Sulawesi, Indonesia. IJDE. 2020; 5 (4): 54-60. doi: 10.11648/j.ijde.20200504.11.
3. Pamungkas RA, Chamroonsawasdi K. Family functional-based coaching program on healthy behavior for glycemic control among Indonesian communities: A quasi-experimental study. Oman Med J. 2020; 35 (5): e173-e173. doi: 10.5001/omj.2020.115.
4. Badan Penelitian dan Pengembangan Kesehatan. Hasil Utama RISKESDAS 2018. Kementerian Kesehatan RI; 2018.
5. Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018; 9: 754. doi: 10.3389/fimmu.2018.00754.
6. Banait T, Wanjari A, Danade V, Banait S, Jain J. Role of high-sensitivity C-reactive protein (hs-crp) in non-communicable diseases: A review. Cureus. 2022; 14 (10): e30225. doi: 10.7759/cureus.30225.
7. Vinod AM, Ganesh A, Manikandan M, Rakchna M. Relationship between serum high-sensitivity C-reactive protein (hs-CRP) and glycated hemoglobin (HbA1c) in South Indian population. Biomedicine. 2023; 43 (01): 310-316. doi: 10.51248/.v43i01.1537.
8. Kawamoto R, Tabara Y, Kohara K, Miki T, Kusunoki T, Takayama S, et al. Association between fasting plasma glucose and high-sensitivity C-reactive protein: gender differences in a Japanese community-dwelling population. Cardiovasc Diabetol. 2011; 10 (1): 51. doi: 10.1186/1475-2840-10-51.
9. Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, et al. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci. 2020; 21 (17): 6275. doi: 10.3390/ijms21176275.
10. Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010; 107 (9): 1058-1070. doi: 10.1161/CIRCRESAHA.110.223545.
11. Hadi HA, Suwaidi JA. Endothelial dysfunction in diabetes mellitus. Vasc Health Risk Manag. 2007: 3 (6) 853–876.
12. Banerjee D, Winocour P, Chowdhury TA, De P, Wahba M, Montero R, et al. Management of hypertension and renin-angiotensin-aldosterone system blockade in adults with diabetic kidney disease: Association of British Clinical Diabetologists and the Renal Association UK guideline update 2021. BMC Nephrol. 2022; 23 (1): 9. doi: 10.1186/s12882-021-02587-5.
13. Lastra G, Syed S, Kurukulasuriya LR, Manrique C, Sowers JR. Type 2 diabetes mellitus and hypertension. Endocrinol Metab Clin North Am. 2014; 43 (1): 103-122. doi: 10.1016/j.ecl.2013.09.005.
14. Ghule A, Kamble TK, Talwar D, Kumar S, Acharya S, et al. Association of serum high sensitivity C-reactive protein with pre-diabetes in rural population: a two-year cross-sectional study. Cureus. 2021; 13 (10): e19088. doi: 10.7759/cureus.19088.
15. Shih YL, Lin Y, Chen JY. The association between high-sensitivity C-reactive protein and metabolic syndrome in an elderly population aged 50 and older in a community receiving primary health care in Taiwan. Int J Environ Res Public Health. 2022; 19 (20): 13111. doi: 10.3390/ijerph192013111.
16. Lima LM, Carvalho MDG, Soares AL, Sabino AP, Fernandes AP, Novelli BA, et al. High-sensitivity C-reactive protein in subjects with type 2 diabetes mellitus and/or high blood pressure. Arq Bras Endocrinol Metabol. 2007; 51 (6): 956-960. doi: 10.1590/S0004-27302007000600010.